← Latest Filings
B
Baynes Roy D.
Open-market buys
0
$0 total
Open-market sells
18
$9.4M total
Tracking since
Nov 2024
Activity timeline
Open-market sale — $225K
Travere Therapeutics, Inc. · Jun 12, 2026
Open-market sale — $210K
Travere Therapeutics, Inc. · May 5, 2026
Open-market trades from the last two years.
Holdings as last reported
134,088 Stock Option (Right to Buy) in EIKN
Held directly · as of 2026-03-02
44,964 Stock Option (right to buy) in AARD
Held directly · as of 2026-08-14
Companies touched
Travere Therapeutics, Inc.
CIK 0001438533
Nurix Therapeutics, Inc.
CIK 0001549595
